Literature DB >> 240395

Competitive inhibitors of renin. Inhibitors effective at physiological pH.

J Burton, K Poulsen, E Haber.   

Abstract

Previously we reported the development of competitive inhibitors of renin effective at pH 5.5 (Poulsen, K., Burton, J., and Haber, E. (1973), Biochemistry 12, 3877). At physiologic pH (7.5), the inhibitory constants (Ki) increased and solubility decreased to the point that inhibition could not be demonstrated with these peptides. Modification of the octapeptide sequence, His-Pro-Phe-His-Leu-Leu-Val-Tyr, either by addition of serinol to the carboxyl terminus or by replacement of valine-7 with an isosteric threonyl residue failed to yield peptides active at pH 7.5. Attachment of polyproline sequences to the amino terminus increased solubility from threefold to tenfold and decreased Ki so that competitive inhibition was demonstrable at physiologic pH. In addition, if leucine-6 was replaced in these peptides with a phenylalanyl or tyrosyl residue, Ki decreased (3-12 muM) to give effective competitive inhibitors at physiologic pH in both buffer and in plasma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240395     DOI: 10.1021/bi00688a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Order in supported phospholipid monolayers detected by the dichroism of fluorescence excited with polarized evanescent illumination.

Authors:  N L Thompson; H M McConnell; T P Burhardt
Journal:  Biophys J       Date:  1984-12       Impact factor: 4.033

2.  Synthesis of peptides related to the prosegment of mouse submaxillary gland renin precursor: an approach to renin inhibitors.

Authors:  G Evin; J Devin; B Castro; J Menard; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 3.  Renin inhibitors as possible antihypertensive agents.

Authors:  K G Hofbauer; J M Wood
Journal:  Klin Wochenschr       Date:  1988-09-15

4.  Synthetic peptide substrates for the immunoglobulin A1 protease from Neisseria gonorrhoeae (type 2).

Authors:  S G Wood; J Burton
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

5.  In vitro studies on an antagonist of parathyroid hormone [Nle-8, Nle-18, Tyr-34]bPTH-(3-34)amide.

Authors:  D A Gray; J A Parsons; J T Potts; M Rosenblatt; R W Stevenson
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

6.  Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.

Authors:  J Burton; R J Cody; J A Herd; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Analogues of an in vitro parathyroid hormone inhibitor: modifications at the amino terminus.

Authors:  M Rosenblatt; J T Potts
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

Review 8.  Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules.

Authors:  Krishnappa Ramya; Ramalingam Suresh; Honnavalli Yogish Kumar; B R Prashantha Kumar; N B Sridhara Murthy
Journal:  Bioorg Med Chem       Date:  2020-03-28       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.